|
Market Closed -
Nasdaq
16:00:00 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 0.8534 USD | +0.40% |
|
+8.71% | +23.20% |
| 08-17 | Cellution Biologics Llc completed the acquisition of SimpliDerm human acellular dermal matrix business of Elutia Inc. for $11 million. | CI |
| 08-13 | Elutia Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ELUT | Delayed | |
CBOE
| ELUT | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bullish |
| Resistance | 0.9018 | 1.01 | 1.17 |
| Spread/Res. | -5.37% | -15.50% | -27.06% |
| Spread/Supp. | +8.71% | +8.71% | +7.02% |
| Support | 0.785 | 0.785 | 0.7974 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ELUT Stock
- Charts Elutia Inc.
Select your edition
All financial news and data tailored to specific country editions
